Leaflet IMAXEMA 20mg / g+1mg / g cream
Product code: W71614001 Quantity: 1
Indicated for: inflammatory dermatoses
Route of administration: cutaneous
Substance: fusidic acid + betamethasone (antibacterial antibiotic + glucocorticoid)
ATC: D07CC01 (Dermatologicals | Corticosteroids, combinations with antibiotics | Corticosteroids, potent, combinations with antibiotics)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
The combination of fusidic acid and betamethasone is used to treat bacterial skin infections accompanied by severe inflammation. Fusidic acid is an antibiotic effective against gram-positive bacteria, particularly Staphylococcus aureus, while betamethasone is a potent corticosteroid that reduces inflammation, redness, and itching.
This combination is indicated for conditions such as infected dermatitis, infected eczema, or other inflammatory skin infections. Fusidic acid addresses the bacterial infection, while betamethasone alleviates inflammatory symptoms, promoting faster healing and greater patient comfort.
It is important to use this combination as directed by a doctor, as prolonged or excessive use of corticosteroids can lead to skin thinning or other side effects. The treatment should be limited to affected areas and should not be applied to open wounds or healthy skin.
General data about IMAXEMA 20mg / g+1mg / g
- Substance: fusidic acid + betamethasone
- Date of latest medicines list: 01-02-2026
- Product code: W71614001
- Concentration: 20mg / g+1mg / g
- Pharmaceutical form: cream
- Quantity: 1
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for fusidic acid + betamethasone
- 20mg/1mg/g
- 20mg/g+1mg/g